Cargando…
Preventive efficacy of oral moxidectin at various doses and dosage regimens against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs
BACKGROUND: Moxidectin has previously shown limited efficacy (≤ 44.4%) against confirmed macrocyclic lactone (ML)-resistant Dirofilaria immitis strains at 3 µg/kg after single and multiple oral dosages. Three studies were conducted to evaluate higher oral moxidectin doses for efficacy against confir...
Autores principales: | McTier, Tom L., Six, Robert H., Pullins, Aleah, Chapin, Sara, Kryda, Kristina, Mahabir, Sean P., Woods, Debra J., Maeder, Steven J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737633/ https://www.ncbi.nlm.nih.gov/pubmed/31506088 http://dx.doi.org/10.1186/s13071-019-3685-3 |
Ejemplares similares
-
Moxidectin: heartworm disease prevention in dogs in the face of emerging macrocyclic lactone resistance
por: Savadelis, Molly D., et al.
Publicado: (2022) -
Efficacy of oral moxidectin against susceptible and resistant isolates of Dirofilaria immitis in dogs
por: McTier, Tom L., et al.
Publicado: (2017) -
Laboratory and field studies to investigate the efficacy of a novel, orally administered combination product containing moxidectin, sarolaner and pyrantel for the prevention of heartworm disease (Dirofilaria immitis) in dogs
por: Kryda, Kristina, et al.
Publicado: (2019) -
Preventive efficacy of four or six monthly oral doses of 24 µg/kg moxidectin compared to six monthly doses of Heartgard® Plus or Interceptor® Plus against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs
por: Kryda, Kristina, et al.
Publicado: (2020) -
Genetic profiles of ten Dirofilaria immitis isolates susceptible or resistant to macrocyclic lactone heartworm preventives
por: Bourguinat, Catherine, et al.
Publicado: (2017)